CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +23.8% | +999.0% | -23.9% | +40.7% | +91.3% | +0.3% | +80.4% | +125.8% | -20.8% | |
| – | +22.6% | +999.1% | -26.0% | +43.9% | +94.2% | +0.1% | +66.3% | +139.6% | -23.8% | |
| – | +16.8% | +216.9% | -10.3% | +130.8% | +115.6% | -83.7% | +68.0% | +381.9% | -61.6% | |
| – | +16.8% | +1,054.7% | -27.8% | +44.3% | +95.3% | +0.2% | +67.0% | +142.4% | -24.1% | |
| – | +919.4% | +115.8% | -13.0% | +33.0% | +10.7% | +19.5% | +285.6% | -9.4% | -93.0% | |
| – | +43.9% | – | – | – | – | – | – | – | – | |
| – | +78.6% | +958.0% | +52.6% | -16.2% | -12.9% | +5.7% | – | – | – | |
| – | +62.8% | -63.5% | +18.3% | +9.7% | +31.3% | +88.0% | +168.5% | +14.1% | +30.6% | |
| – | +0.8% | +783.5% | +5.2% | +25.8% | +52.5% | +73.3% | +58.5% | +35.8% | +42.5% | |
| – | – | – | – | +130.7% | -43.8% | +11.9% | +297.1% | +71.4% | -9.3% | |
| – | +18.5% | +261.3% | +85.3% | +29.3% | +22.4% | +61.3% | -4.9% | -10.6% | +286.3% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +44.2% | +96.5% | -4.7% | +70.4% | +145.7% | -25.1% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -12.5% | +99.1% | +25.9% | +26.2% | +35.2% | +11.7% | +39.1% | +16.4% |
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.